To learn more about recent and upcoming presentations, please contact csdd@tufts.edu.
Upcoming Presentations
Examining the Vendor Qualification and Selection Process
Ken Getz
CORE East
Live | October 4-6
Overcoming Barriers Slowing the Adoption of Disruptive Technologies
Maria Florez
Disruptive Technologies in Clinical Trials
Boston, MA | October 10
Adopting Technologies that Enable Digital Transformations
Maria Florez
Precision in Clinical Trials Summit
San Diego, CA | October 16
Envisioning the Future Landscape: Preparing the Future Workforce for Drug Research & Development - A Workshop
Mary Jo Lamberti
National Academies
Washington D.C. | October 16-17
Clinical Trial Disruptions During Disasters and Public Health Emergencies
Ken Getz
CTTI and FDA public meeting
Virtual | October 18 - 19
Benchmarking Patient Enrollment and Use of Patient Recruitment Tactics
Outsourcing in Clinical Trials New England
Boston, MA | November 1
Optimizing Clinical Trial Performance
Ken Getz, MBA
OCT New England
Live | November 2
Assessing the Net Financial Benefits of Employing Digital Endpoint in Clinical Trials
Joseph DiMasi, PhD
4th Annual Digital Biomarkers & Digital Measurements East Summit
Boston, MA | November 2
Measuring Patient and Site Burden in Clinical Trials
Ken Getz, MBA
DIA Annual Meeting Japan
Live | November 5 - 8
Diversity and Representation in Oncology Trials
Zachary Smith, MA
Cancer Immunotherapy Summit
Boston, MA | Nov 6 - 8
Leveraging Patient Engagement Strategies to Optimize Protocol Performance
Ken Getz
Evolution Summit
Live | December 4
September 2023
Patient Preferences for Virtual and Remote Clinical Trial Services
Ken Getz, MBA
DPharm
Live | September 22
Increasing R&D Productivity to Sustain Biomedical Innovation
Ken Getz
IQVIA Institute Life Sciences Innovation Forum
Virtual | September 26
August 2023
How Lack of Inclusion Can Impact Women In STEM
Jennifer Kim, PhD
Cornell School of Medicine
Live | August 31st
Methods in Organizational Change Research: Dialogue on the Past, Present, and Future of Organization
Jennifer Kim, PhD
Academy of Management
Boston, MA | August
Silence is Not Always Golden: Impact of Leader Intervention Against COVID-19 Microaggressions
Jennifer Kim, PhD
Academy of Management
Boston, MA | August
July 2023
A Site Perspective: The Impact of the Last 5 Years
Abigail Dirks, MS
Clinical Operations in Oncology Trials East Coast
Boston, MA | July 11
June 2023
Performance, Interrupted: Examining DEI Dynamics That can Impact Team Performance in Drug Development
Jennifer Kim, PhD
DIA Annual Meeting
Boston, MA | June 26 - 29
Measuring Impact of Patient Engagement Across Research and Development
Jennifer Kim, PhD
DIA Annual Meeting
Boston, MA | June 26 - 29
Sponsor-CRO Collaborations and the Impact of Decentralized Clinical Trials
Mary Jo Lamberti, PhD
DIA Annual Meeting
Boston, MA | June 26
Maximizing Diversity in Clinical Trials
Ken Getz, MBA
Finn Partners
Boston, MA | June 20
The Impact of Patient Engagement on Drug Development Performance
Ken Getz, MBA
DIA China
Virtual | June 17
The Impact of the Last 5 Years on Investigative Sites
Abigail Dirks, MS and Ken Getz, MBA
ACRP
Virtual | June 14
Clinical Trials for Small Biotechs
Ken Getz, MBA
STAT News
Virtual | June 12
May 2023
Innovation in Clinical Research: Why it Takes So Long to Adopt a New Solution
Ken Getz, MBA
MAGI East Conference
Philadelphia, PA | May 21 - 24
Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs
Joseph DiMasi
PhRMA R&D Roundtable
Boston, MA | May 11
Managing Protocol Complexity to Optimize Clinical Trial Performance
Ken Getz, MBA
Linking Leaders
Boston, MA | May 10
April 2023
The Economics of Implementing Phase 0 Techniques - Methods for Measuring Financial Value
Joseph DiMasi, PhD
4th International Phase-0/Microdosing Stakeholder Meeting: Intra-Target Microdosing (ITM): Revolutionizing Clinical Pharmacology and Drug Development
Boston, MA | April 24
The Impact of DCT Use of Sponsor-CRO Relationships
Mary Jo Lamberti, PhD
Informa Decentralized Clinical Trials
Boston, MA | April 19
Quantifying the Value Proposition of DCT Deployment
Ken Getz, MBA
Informa Decentralized Clinical Trials
Boston, MA | April 18 - 20
State of the Drug Development Industry
Ken Getz, MBA
Chief Medical Officers Summit
Boston, MA | April 3 - 4
March 2023
Assessing Patient Engagement Capabilities and Their Impact
Ken Getz, MBA
DIA Europe
Basel, Switzerland | March 23
Examining Current Patient Engagement Activities and Investment Within Sponsor and CRO Companies
Ken Getz, MBA
DIA Europe
Basel, Switzerland | March 22
February 2023
The Impact of Decentralized and Hybrid Trials on Sponsor-CRO Collaborations
Mary Jo Lamberti, PhD
SCOPE Summit
Orlando, FL | December 8
Panel Discussion- Navigating Global Crises: Pandemic War, Hyperinflation and Supply Chain
Ken Getz, MBA
SCOPE Summit
Orlando, FL | February 7
January 2023
Remote Teams in Clinical Research During the COVID-19 Pandemic
Maria Florez, MA and Mary Jo Lamberti, PhD
Clinical Research Webinar
Virtual | January 26-27
Clinical Operations and Clinical Outsourcing Roundtables
Ken Getz, MBA
Linking Leaders
New York, NY | January 17-18
December 2022
New Insights into Managing Investigative Sites to Optimize Patient Enrollment Diversity
Ken Getz, MBA
Evolution Summit
Orlando, FL | December 8
Clinical Research Professionals and the Shift to Remote Work During the COVID-19 Pandemic
Maria Florez, MA and Mary Jo Lamberti, PhD
Clinical Operations in Oncology, Virtual Conference
Virtual | December 1
November 2022
Measuring the Impact of the Pandemic on Drug Development Productivity and Performance
Ken Getz, MBA
Outsourcing Clinical Trials New England
Boston, MA | November 10
New Trends and Practices Impacting the Drug Development Landscape
Ken Getz, MBA
CT Europe
Live | November 7-9
Increasing Efficiency and Reducing Cycle-Times in Drug Development: Multi-Stakeholder Views on the Topic
Zachary Smith, MA
Clinical Trials Europe
Virtual | November 3
Where Has the Industry Been and Where Should it Be Going?
Joseph DiMasi, PhD
Speid & Associates Inc. and Brown University Medical School
Virtual | November 2-4
Impact of Running Clinical Trials During the Pandemic and Lessons Learnt
Ken Getz, MBA and Maria Florez, MA
Clinical Trials Europe
Virtual | November 2-4
Digital Transformation and Clinical Research Team Effectiveness
Maria Florez, MA
Clinical Trials Europe
Virtual | November 2-4
Optimizing Protocol Design to Improve Performance and Efficiency
Ken Getz, MBA
Clinical Trials Europe
Virtual | November 2
October 2022
Digitizing Clinical Trials
Maria Florez, MA
18th Clinical Trials Innovation Programme
Boston, MA | October 26-27
The Economics of Decentralized Clinical Trials: Assessing the Net Financial Benefit
Joseph DiMasi, PhD
Decentralized Clinical Trials Summit
Philadelphia, PA | October 26
Accommodating and Managing Agile Drug Development Execution
Ken Getz, MBA
Chief Medical Officers Summit
Virtual | October 14
Exploring the Impact of Decentralized Clinical Trials
Ken Getz, MBA
Prometrika
Live & Virtual | October 13
The Impact of Decentralized Trials on Sponsor-CRO Collaborations
Mary Jo Lamberti, PhD
Outsourcing in Clinical Trials New England
Boston, MA | October 12-13
Impact of COVID-19 on Clinical Operations
Ken Getz, MBA
Dutch Federation of Pharmaceutical Medicine
Virtual | October 7
Diversity and Representation Among the Clinical Research Workforce: A factor in patient engagement and recruitment?
Maria Florez, MA
Scope Europe
Barcelona | October 3-4
Characterizing the Innovation Adoption Cycle for Innovations Supporting Virtual Clinical Trials
Maria Florez, MA
Scope Europe
Barcelona | October 3-4
September 2022
Ken Getz, MBA
DPharm
Virtual | September 29
Maria Florez, MA
Precision in Clinical Trials Summit
Frankfurt | September 28
Emily Botto, BA
Clinical Trials Global
Virtual | September 28
Ken Getz, MBA
CTTI Fall Steering Committee Meeting
Washington D.C. | September 20
Emily Botto, BA
Contract Pharma
New Brunswick, NJ | September 20
Ken Getz, MBA
IQVIA Life Sciences Innovation Forum
Virtual | September 13
Ken Getz, MBA
RBQM Live
Virtual | September 8